Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-28 Sale |
2022-03-01 9:13 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
14,635 | $2.7795 | $40,678 | 935,319 (Indirect Direct) |
View |
| 2022-02-28 Sale |
2022-03-01 9:12 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,395 | $2.7795 | $6,657 | 93,849 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-01 9:10 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,998 | $2.7795 | $11,112 | 165,404 (Direct) |
View |
| 2021-11-26 Sale |
2021-11-29 7:50 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,541 | $4.8112 | $21,847 | 96,244 (Direct) |
View |
| 2021-11-26 Sale |
2021-11-29 7:48 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
7,579 | $4.8112 | $36,464 | 169,402 (Direct) |
View |
| 2021-11-26 Sale |
2021-11-29 7:46 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
27,747 | $4.8112 | $133,495 | 942,954 (Indirect Direct) |
View |
| 2021-11-15 Purchase |
2021-11-15 5:59 pm |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
8,000 | $5.56 | $44,480 | 567,198 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-17 Option Award |
2022-03-18 5:34 pm |
N/A 2032-03-17 |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:32 pm |
N/A 2032-03-17 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
412,500 | $0 | 412,500 (Direct) |
View |
| 2022-02-25 Exercise |
2022-03-01 9:13 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
25,219 | $0 | 935,319 (Direct) |
View |
| 2022-02-25 Exercise |
2022-03-01 9:12 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 93,849 (Direct) |
View |
| 2022-02-25 Exercise |
2022-03-01 9:11 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
9,034 | $0 | 144,547 (Direct) |
View |
| 2022-02-25 Exercise |
2022-03-01 9:10 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 165,404 (Direct) |
View |
| 2021-12-29 Exercise |
2021-12-30 6:47 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
7,000 | $0.9 | 657,688 (Direct) |
View |
| 2021-12-29 Exercise |
2021-12-30 6:47 pm |
N/A 2029-02-13 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
7,000 | $0 | 657,688 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-29 7:51 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
18,068 | $0 | 144,547 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-29 7:50 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
8,254 | $0 | 96,244 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-29 7:48 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
13,777 | $0 | 169,402 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-29 7:46 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
50,437 | $0 | 942,954 (Direct) |
View |
| 2021-09-28 Exercise |
2021-09-29 6:04 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
10,000 | $0.9 | 155,577 (Direct) |
View |
| 2021-09-28 Exercise |
2021-09-29 6:04 pm |
N/A 2029-07-30 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
10,000 | $0 | 155,577 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-17 6:11 pm |
N/A 2031-08-16 |
Viracta Therapeutics Inc. | VIRX | Borellini Flavia Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-17 6:10 pm |
N/A 2031-08-16 |
Viracta Therapeutics Inc. | VIRX | Barlow Jane F Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-01 5:49 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
12,000 | $0.9 | 155,577 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-01 5:49 pm |
N/A 2029-07-30 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
12,000 | $0 | 155,577 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 5:46 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
32,689 | $1.26 | 163,775 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 5:46 pm |
N/A 2030-07-08 |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
34,750 | $0 | 163,775 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 5:46 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,061 | $3.58 | 163,775 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:28 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
126,890 | $0 | 126,890 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:25 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | ONETTO NICOLE Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:23 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Huang Michael Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:21 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:18 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Roshwalb Gur Director 10% Owner |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:16 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | DARCY THOMAS E Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:13 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Murphy Samuel Lafayette Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:11 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Pomerantz Roger Director |
135,000 | $0 | 135,000 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:07 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Rubino Stephen Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:03 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | ROYSTON IVOR CEO & President |
441,993 | $0 | 441,993 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:00 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
78,912 | $0 | 78,912 (Direct) |
View |
Ownership |
2021-03-04 5:46 pm |
N/A 2028-12-15 |
Viracta Therapeutics Inc. | VIRX | Simon Barry J. Director |
0 | $0 | 11,190 (Direct) |
View |
Ownership |
2021-02-25 6:09 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | VIRX | aMoon 2 Fund Limited Partnership Schindel Yair Chaim 10% Owner |
0 | $0 | 7,392,237 (Direct) |
View |
Ownership |
2021-02-25 6:03 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | VIRX | Roshwalb Gur Director 10% Owner |
0 | $0 | 7,392,237 (Indirect) |
View |
Ownership |
2021-02-24 8:10 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | VIRX | Chevallard Daniel R. Chief Executive Officer |
0 | $0 | 320,908 (Direct) |
View |
Ownership |
2021-02-24 7:45 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | VIRX | Pomerantz Roger Director |
0 | $0 | 347,545 (Direct) |
View |
Ownership |
2021-02-24 7:40 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | VIRX | Rojkjaer Lisa Chief Medical Officer |
0 | $0 | 295,187 (Direct) |
View |